Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 3
2004 6
2005 1
2007 2
2008 1
2009 1
2010 2
2011 6
2012 11
2013 3
2014 6
2015 5
2016 3
2017 4
2018 7
2019 11
2020 8
2021 6
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Management of Subcutaneous Soft Tissue Sarcoma.
Endo M, Setsu N, Fujiwara T, Ishii T, Nakagawa M, Yahiro K, Kimura A, Shimada E, Nakashima Y, Matsumoto Y. Endo M, et al. Among authors: nakagawa m. Curr Treat Options Oncol. 2019 May 25;20(7):54. doi: 10.1007/s11864-019-0656-z. Curr Treat Options Oncol. 2019. PMID: 31129726 Review.
Prognostic impact of IDH mutations in chondrosarcoma.
Nakagawa M, Sekimizu M, Endo M, Kobayashi E, Iwata S, Fukushima S, Yoshida A, Kitabayashi I, Ichikawa H, Kawai A, Nakatani F. Nakagawa M, et al. J Orthop Sci. 2022 Nov;27(6):1315-1322. doi: 10.1016/j.jos.2021.07.024. Epub 2021 Sep 14. J Orthop Sci. 2022. PMID: 34531086
Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.
Ogiwara Y, Nakagawa M, Nakatani F, Uemura Y, Zhang R, Kudo-Saito C. Ogiwara Y, et al. Among authors: nakagawa m. Cancer Lett. 2022 Jul 1;537:215690. doi: 10.1016/j.canlet.2022.215690. Epub 2022 Apr 16. Cancer Lett. 2022. PMID: 35439537
Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors.
Shinohara H, Sawado R, Nakagawa M, Hattori A, Yamagata K, Tauchi K, Ito J, Kuwahara Y, Okuda T, Ogawa C, Kitabayashi I. Shinohara H, et al. Among authors: nakagawa m. Mol Ther Oncolytics. 2022 Sep 19;27:14-25. doi: 10.1016/j.omto.2022.09.006. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36212776 Free PMC article.
92 results